Structural valve deterioration in the Mitroflow biological heart valve prosthesis.

about

Structural valve deterioration in the Mitroflow biological heart valve prosthesis.

Item

http://www.wikidata.org/entity/Q42696805

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Structural valve deterioration in the Mitroflow biological heart valve prosthesis.

@en

Structural valve deterioration in the Mitroflow biological heart valve prosthesis.

@nl

type

Item

label

Structural valve deterioration in the Mitroflow biological heart valve prosthesis.

@en

Structural valve deterioration in the Mitroflow biological heart valve prosthesis.

@nl

prefLabel

Structural valve deterioration in the Mitroflow biological heart valve prosthesis.

@en

Structural valve deterioration in the Mitroflow biological heart valve prosthesis.

@nl

P1476

Structural valve deterioration in the Mitroflow biological heart valve prosthesis

@en

P2093

Christian Torp Pedersen

http://www.w3.org/2001/XMLSchema#string

Martin Agge Nørgaard

http://www.w3.org/2001/XMLSchema#string

Per Hostrup Nielsen

http://www.w3.org/2001/XMLSchema#string

Peter Søgaard

http://www.w3.org/2001/XMLSchema#string

Steen Hvitfeldt Poulsen

http://www.w3.org/2001/XMLSchema#string

P2860

Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention.

Guidelines for reporting mortality and morbidity after cardiac valve interventions.

Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions.

Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants

Mitroflow aortic pericardial bioprosthesis--clinical performance.

Choice of prosthetic heart valve in adults an update.

Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves.

Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.

Long-Term Outcomes and Durability of the Mitroflow Aortic Bioprosthesis.

P304

136-142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EJCTS/EZX321

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29029140

http://www.w3.org/2001/XMLSchema#string